Monday, October 16, 2006
The charges came in an information, which typically indicates a guilty plea is forthcoming; indeed, Crawford is apparently scheduled to appear in front of a magistrate today. The charges relate to a couple of alleged conflicts of interest:
The papers state that Crawford failed to disclose his income from exercising stock options in Embrex Inc. of Research Triangle Park, N.C., an agriculture biotechnology company regulated by FDA.
Crawford had been a member of the board of directors of Embrex, according to federal filings.
The court papers also say that Crawford chaired FDA's Obesity Working Group at a time when he and his wife owned stock in soft drink and snack food manufacturer Pepsico Inc., based in Purchase, N.Y., and food product manufacturer Sysco Corp., based in Houston.
The panel Crawford was chairing was making decisions affecting food and soft drink manufacturers.